Hyperbilirubinemia Treatment Market Set to Record Exponential Growth by 2025
Hyperbilirubinemia, also referred to as neonatal jaundice is a very common problem in newborns. It is a disorder in which level of bilirubin in the blood become high. Bilirubin is a substance, which is formed in the blood when the red blood cells breakdown. Treatment of the bilirubin is not easy in newborns. Moreover, it can increase fluids and other tissues of the baby's body. It is curable and revocable, if appropriately treated. However, its aggravation could cause sequela into...
View full press release